PAR 2.17% 23.5¢ paradigm biopharmaceuticals limited..

General OA media and info, page-222

  1. 1,564 Posts.
    lightbulb Created with Sketch. 164

    Thanks for alerting us to this trial Upmarket and
    for trial details jcurve.

    ”The (pilot) study outcomes revealed oral PPS
    significantly improved pain, stiffness and other
    functional measures in these patients”.

    We have been led to believe that oral PPS
    is virtually useless for OA treatment.

    If that is true, why is David Hunter (of all
    people) involved with this study. Just for
    ”shits and giggles” or waste some money.

    As I understand it, PAR has no patents or
    agreement with Bene to trial or market the
    oral version of PPS.

 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.5¢
Change
0.005(2.17%)
Mkt cap ! $82.20M
Open High Low Value Volume
23.5¢ 24.0¢ 23.3¢ $111.8K 474.5K

Buyers (Bids)

No. Vol. Price($)
6 154744 23.5¢
 

Sellers (Offers)

Price($) Vol. No.
24.0¢ 21128 2
View Market Depth
Last trade - 16.10pm 14/06/2024 (20 minute delay) ?
Last
23.5¢
  Change
0.005 ( 2.17 %)
Open High Low Volume
23.5¢ 24.0¢ 23.5¢ 63872
Last updated 15.59pm 14/06/2024 ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.